FIDELIO Healthcare

What FIDELIO Healthcare does

FIDELIO Healthcare is a German Contract Development and Manufacturing Organization (CDMO) headquartered in Limburg an der Lahn. The legal entity was formed in October 2018 when it acquired the production facilities and associated business operations of Mundipharma GmbH, which had operated continuously at the Limburg site since 1967 (with relocation to the current campus in 1975). The company occupies a Bauhaus-designed facility originally constructed in 1973 by architect Marcel Breuer, now a listed building, comprising production halls, laboratories, offices, a high-bay warehouse with 3,500 pallet capacity and a controlled-drug storage facility with 600 pallet spaces.

Name

FIDELIO Healthcare

Legal name

FIDELIO Healthcare Limburg GmbH

Website

https://fidelio-hc.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

101–250 employees

Short description

FIDELIO Healthcare is a German privately held CDMO that develops and manufactures pharmaceuticals, controlled drugs and narcotics, medical devices and dietary supplements in multiple dosage forms (soft gelatine capsules, tablets, semi-solid and liquid forms) for pharmaceutical and healthcare customers in Germany, Europe, the USA, Japan and worldwide export markets.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)

akta.pro secondary industries

Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI), Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

• Pharmaceutical contract manufacturing
• Contract development services
• Soft gelatine capsules
• Controlled drugs manufacturing
• GMP contract manufacturing

Headquarters

HQ city

Limburg An Der Lahn

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Contract Manufacturing Services: Manufacturing of pharmaceutical products, controlled drugs, medical devices, and food supplements for customer brands. Services include commercial production, product and process optimization, quality assurance, quality control, warehousing and logistics, and supply chain management. Revenue generated through manufacturing fees based on production volumes and complexity.
2. Product Development Services: Research and development services including formulation development, analytical method development, stability studies, scale-up from development to commercial production, and CMC documentation preparation for regulatory submissions.
3. Regulatory Approval Services: Regulatory filing and approval services for market launch of new products in various target markets worldwide, including direct contact with regulatory authorities or coordination through partners.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

FIDELIO Healthcare is a German Contract Development and Manufacturing Organization (CDMO) producing pharmaceuticals, narcotics (including cannabis-based products), medical devices, and food supplements for customer brands. The company provides end-to-end services spanning product development (formulation, analytical method development, stability studies), regulatory approval and filing, commercial manufacturing across solid, semi-solid, liquid, and soft gelatine capsule dosage forms, quality assurance/control, packaging, serialization, warehousing, and global logistics. Operations run from a single GMP-certified production facility in Limburg an der Lahn, Germany, with certifications for export to the USA, Japan, and other major worldwide markets.

Product overview

FIDELIO Healthcare is a diversified European Contract Development and Manufacturing Organization (CDMO) in the pharmaceutical and healthcare industry. The company operates as a single unified service offering spanning the entire product lifecycle: from Product Development (including formulation development for soft gelatine capsules, solid forms, semi-solid forms, and liquid forms, plus regulatory approval services) through Contract Manufacturing (commercial production, product & process optimization, quality assurance, quality control, warehousing & logistics, and supply chain management) to Target Markets (Germany/Europe and worldwide export). The product portfolio is organized around two main axes: Technology & Pharmaceutical Forms (soft gelatine capsules, solid forms, semi-solid forms, liquid forms, and packaging) and Regulatory Categories (medicinal products, controlled drugs/narcotics, medical devices, and food supplements). The company is certified for major export countries including the USA and Japan, and operates from a production facility in Limburg an der Lahn, Germany.

Differentiator

Problem solved

Functional benefit

Products and services

• Commercial Manufacturing (Contract Manufacturing / Lohnfertigung) Large-scale pharmaceutical contract manufacturing using modern machinery, covering solid forms (tablets, hard gelatin capsules, film-coated tablets), soft gelatine capsules, semi-solid forms (ointments, creams, pastes, gels), liquid forms (solutions, emulsions, suspensions), and suppositories for pharmaceutical and healthcare company customers. Capable of producing large batches efficiently, e.g., filming one million tablets in a single run.
• Product Development (Forschung & Entwicklung) Research and development services including formulation development for solid, semi-solid, and liquid pharmaceutical forms, stability studies in climate chambers covering all relevant climate zones, analytical method development and testing in in-house laboratories, scale-up from development to commercial production, and preparation of CMC documentation for regulatory submissions. Targeted at pharmaceutical, medical device, and food supplement companies needing new product development.
• Regulatory Approval Services (Zulassung) Regulatory filing and approval services for market launch of new medicinal products, including handling of approval procedures in major target markets, direct contact with regulatory authorities, or coordination through local partners. Covers worldwide markets with knowledge of country-specific requirements.
• Product & Process Optimization (Produkt- & Prozessoptimierung) Optimization services for existing products including deep analysis of manufacturing processes, identification of weaknesses, and application of expertise to make products safer or improve effectiveness. Targeted at companies with established products seeking manufacturing or formulation improvements.
• Quality Assurance (Qualitätssicherung) Quality assurance services coordinating information flow across development, production, and supporting functions, evaluating and initiating necessary quality measures before final release of pharmaceutical products, narcotics, medical devices, and food supplements.
• Quality Control (Qualitätskontrolle) Quality control laboratory services including inspection of all incoming raw materials, regular spot checks throughout processing, and final product testing using HPLC, GC systems, and dissolution studies for purity, content, identity, and drug release characterization.
• Warehousing & Logistics (Lager & Logistik) Storage and logistics services with high-bay warehouse capacity of 3,500 pallets and controlled drugs storage of 600 pallet spaces under controlled temperature and humidity, including cooperation with specialized logistics service providers for worldwide transportation.
• Supply Chain & Customer Service Supply chain management services ensuring timely availability of materials from qualified suppliers, coordination of deliveries, and customer service handling inquiries related to delivery status, new projects, and other customer needs.

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Eurofins CDMO: Contract development and manufacturing services within Eurofins' broader testing, inspection, and certification platform. Overlaps with FIDELIO in development, analytical, and pharmaceutical manufacturing services for European pharma customers.
• Lonza Group: Global CDMO leader across biologics, small molecules, and cell/gene therapy manufacturing. A broader incumbent that competes less directly on commodity oral solids but increasingly enters the European oral-solid CDMO space through acquisitions.
• Catalent: Large global CDMO offering oral solids, softgel, biologics, and sterile fill-finish to pharma customers worldwide. A larger incumbent that competes for the same pharma contract manufacturing RFPs but on a much broader technology and geographic footprint.

Direct peers

• Recipharm: Swedish-headquartered CDMO serving pharma customers with oral solids, semi-solids, sterile, and inhalation dosage forms. Overlaps directly with FIDELIO's commercial oral-solid and semi-solid manufacturing focus and Europe-centric geographic footprint.
• Delpharm: French pharmaceutical contract manufacturer specializing in solid, sterile, and biological dosage forms for European pharma customers. Comparable in CDMO service model, regulatory capability, and serving large pharma clients across multiple dosage forms.
• Fareva: French pharmaceutical CDMO with manufacturing across solid, semi-solid, liquid, and sterile forms for pharma and cosmetics customers. Operates at similar scale with comparable service breadth and a European customer focus, making it a direct competitor for similar contract manufacturing engagements.
• Rottendorf Pharma: German CDMO specializing in solid oral dosage forms (tablets, capsules) and development services for European pharma customers. Directly comparable in German CDMO focus, oral-solid specialization, and pharma customer segment.
• Siegfried Holding: Swiss-headquartered CDMO offering API and drug product manufacturing (oral solids, semi-solids, sterile fill-finish) to global pharma customers. Comparable in mid-to-large European CDMO scope, formulation development capabilities, and similar end-markets in branded and generics.
• Aenova Group: One of Europe's largest pharmaceutical contract manufacturers, headquartered in Germany, offering solid, semi-solid, and liquid dosage forms plus soft gelatine capsules. Highly comparable to FIDELIO in technology stack, customer base, and German CDMO focus; notably, FIDELIO's CEO previously led Aenova to global No. 3 CDMO ranking.
• NextPharma: European CDMO providing contract development and manufacturing services for oral solids, liquids, and semi-solids. Comparable in mid-sized European CDMO positioning, customer base, and service offering for pharma customers across multiple geographies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/fidelio-healthcare-limburg-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FIDELIO Healthcare